title: Limited access to HIV prevention in French prisons (ANRS PRI2DE): implications for public health and drug policy.
abstract: BACKGROUND
  Overpopulation, poor hygiene and disease prevention conditions in prisons are major structural determinants of increased infectious risk within prison settings but evidence-based national and WHO guidelines provide clear indications on how to reduce this risk. We sought to estimate the level of infectious risk by measuring how French prisons adhere to national and WHO guidelines.
  
  
  METHODS
  A nationwide survey targeting the heads of medical (all French prisons) and psychiatric (26 French prisons) units was conducted using a postal questionnaire and a phone interview mainly focusing on access to prevention interventions, i.e. bleach, opioid substitution treatment (OST), HBV vaccination and post-exposure prophylaxis (PEP) for French prisoners. Two scores were built reflecting adherence to national and WHO international guidelines, ranging from 0 (no adherence) to 10 (maximum adherence) and 0 to 9 respectively.
  
  
  RESULTS
  A majority (N=113 (66%)) of the 171 prisons answered the questionnaires, representing 74% coverage (46,786 prisoners) of the French prison population: 108 were medical units and 12 were psychiatric units. Inmate access to prevention was poor. The median[IQR] score measuring adherence to national guidelines was quite low (4.5[2.5; 5.5]) but adherence to WHO guidelines was even lower 2.5[1.5; 3.5]; PEP was absent despite reported risky practices. Unsuitable OST delivery practices were frequently observed.
  
  
  CONCLUSIONS
  A wide gap exists between HIV prevention policies and their application in prisons. Similar assessments in other countries may be needed to guide a global policy reform in prison settings. Adequate funding together with innovative interventions able to remove structural and ideological barriers to HIV prevention are now needed to motivate those in charge of prison health, to improve their working environment and to relieve French prisoners from their currently debilitating conditions.
authors: Health and Medical Research National Institute, Research Unit 669, Paris, France. laurent.michel@erx.aphp.fr
authors: Laurent
authors: L
authors: Michel
authors: Marie
authors: M
authors: Jauffret-Roustide
authors: Jerôme
authors: J
authors: Blanche
authors: Olivier
authors: O
authors: Maguet
authors: Christine
authors: C
authors: Calderon
authors: Julien
authors: J
authors: Cohen
authors: Patrizia M
authors: PM
authors: Carrieri
references: Lancet Infect Dis. 2007 Jan;7(1):32-41
references: 17182342
references: Lancet. 2011 Mar 12;377(9769):956-65
references: 21093904
references: Addiction. 2006 Feb;101(2):181-91
references: 16445547
references: BMC Psychiatry. 2006 Aug 21;6:33
references: 16923177
references: Lancet. 2002 Feb 16;359(9306):545-50
references: 11867106
references: Mod Healthc. 2005 Apr 25;35(17):34
references: 15876002
references: Harm Reduct J. 2008 May 21;5:17
references: 18495018
references: Subst Use Misuse. 2005;40(6):831-43
references: 15974143
references: Addiction. 2010 Jul;105(7):1311-2
references: 20642514
references: Lancet Infect Dis. 2009 Jan;9(1):57-66
references: 19095196
references: Drug Alcohol Depend. 2006 Sep 15;84(2):154-9
references: 16481128
references: Addiction. 2009 Feb;104(2):223
references: 19149816
references: BMC Infect Dis. 2009 Jul 16;9:113
references: 19607712